Ausgabe 6/2017
Inhalt (8 Artikel)
Second-Line Therapy for Advanced Colorectal Cancer: EGFR vs. Continuation of VEGF Inhibition
Michael T. Serzan, Benjamin A. Weinberg, Mohamed E. Salem
Conversion Therapy for Initially Borderline/Unresectable Metastases in Colon Cancer: What Is the Best Neoadjuvant Chemotherapy?
Sigurdis Haraldsdottir, Richard M. Goldberg
Diet, Gut Microbiota, and Colorectal Cancer Prevention: a Review of Potential Mechanisms and Promising Targets for Future Research
Mingyang Song, Andrew T. Chan
Dietary Patterns and Colorectal Cancer Risk: a Review of 17 Years of Evidence (2000–2016)
Fred K. Tabung, Lisa S. Brown, Teresa T. Fung
Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology
Laura A. E. Hughes, Colinda C. J. M. Simons, Piet A. van den Brandt, Manon van Engeland, Matty P. Weijenberg
Liver Imaging for Colorectal Cancer Metastases
Daniel R. Ludwig, Aaron J. Mintz, Vanessa R. Sanders, Kathryn J. Fowler
Stool- and Blood-Based Molecular Tests in Screening for Colorectal Cancer: Ready for Prime Time?
Chung Wah Wu, Joseph Jao-Yiu Sung
Author Correction: Chemoprevention of Colorectal Cancer in High-Risk Patients: from Molecular Targets to Clinical Trials
Dora Colussi, Franco Bazzoli, Luigi Ricciardiello